Pfizer PFE FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Pfizer in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pfizer's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pfizer's FX effect on cash?
- Pfizer (PFE) reported FX effect on cash of $19M in Q1 2026.
- How has Pfizer's FX effect on cash changed year-over-year?
- Pfizer's FX effect on cash increased by 371.4% year-over-year, from -$7M to $19M.
- What is the long-term trend for Pfizer's FX effect on cash?
- Over 3 years (2021 to 2025), Pfizer's FX effect on cash has grown at a -11.4% compound annual growth rate (CAGR), from -$59M to $41M.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.